A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice

iNKT-cell help to B cells: A cooperative job between innate and adaptive immune responses

(2014) Paolo Dellabona et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides

(2013) L. Bai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma

(2012) J. Richter et al.   BLOOD

Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells

(2012) Kaoru Nagato et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Follicular Helper NKT Cells Induce Limited B Cell Responses and Germinal Center Formation in the Absence of CD4+ T Cell Help

(2012) E. Tonti et al.   JOURNAL OF IMMUNOLOGY

Activated iNKT Cells Promote Memory CD8+ T Cell Differentiation during Viral Infection

(2012) Emma C. Reilly et al.   PLoS One

Pneumococcal disease in South Australia: Vaccine success but no time for complacency

(2012) David R. Johnson et al.   VACCINE

Serotype replacement in disease after pneumococcal vaccination

(2011) Daniel M Weinberger et al.   LANCET

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses

(2011) Pheh-Ping Chang et al.   NATURE IMMUNOLOGY

Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner

(2011) Irah L King et al.   NATURE IMMUNOLOGY

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

(2011) Fikri Y Avci et al.   NATURE MEDICINE

Fine tuning by human CD1e of lipid-specific immune responses

(2011) F. Facciotti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines

(2011) Karen Richards Tyo et al.   VACCINE

Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement

(2010) C Alexandre et al.   ACTA PAEDIATRICA

Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster

(2010) F. M. Russell et al.   Clinical and Vaccine Immunology

Invariant natural killer T cells: Linking inflammation and neovascularization in human atherosclerosis

(2010) Emmanouil Kyriakakis et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Cutting Edge: Hierarchy of Maturity of Murine Memory B Cell Subsets

(2010) M. M. Tomayko et al.   JOURNAL OF IMMUNOLOGY

Carbohydrate vaccines: developing sweet solutions to sticky situations?

(2010) Rena D. Astronomo et al.   NATURE REVIEWS DRUG DISCOVERY

Recent advances in carbohydrate-based vaccines

(2009) Marie-Lyn Hecht et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in Children

(2009) Elske J. M. van Gils et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Parameters Underlying Distinct T Cell-Dependent Polysaccharide-Specific IgG Responses to an Intact Gram-Positive Bacterium versus a Soluble Conjugate Vaccine

(2009) J. Colino et al.   JOURNAL OF IMMUNOLOGY

A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection

(2009) A. Phalipon et al.   JOURNAL OF IMMUNOLOGY